ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBi that is developing next-generation TCR-based cancer immunotherapies, today announced an exclusive in-licensing deal with Cue ...
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immuno-oncology company developing novel therapeutics to ...
Photos and video of immigrants in custody have been a hallmark of President Donald Trump’s administration, and illustrate his ...
Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation The facility will support CAR-T R&D in potential oncology and immunology indications A Media ...
Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...
Behind the trend is the surging popularity of GLP-1 weight loss medications, a class of so-called peptides approved to help users quickly shed pounds.
The man’s case, which was detailed Wednesday in the Journal of Allergy and Clinical Immunology in Practice, turned out to be ...
In beauty, “algae” refers to a diverse class of marine organisms. This includes macroalgae (aka seaweed — brown, green, red) ...
Florida Fish and Wildlife Conservation Commission (FWC) officers are expressing concerns about their preparedness to make ...
Live Updates Get The Best Vanguard S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top ...
Positive 15%, marking a sequential and year-over-year improvement, supported by reduced product costs and a net reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback